The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Rachel Hu
Allison Winter
Brian T. Hill
机构：
[1] Cleveland Clinic,Taussig Cancer Institute
来源：
Current Oncology Reports | 2019年 / 21卷
关键词：
Diffuse large B cell lymphoma; Circulating tumor DNA; Minimal residual disease; Immunoglobulin next-generation sequencing; Next generation sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma
    Hu, Rachel
    Winter, Allison
    Hill, Brian T.
    CURRENT ONCOLOGY REPORTS, 2019, 21 (05)
  • [2] Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma
    Roschewski, Mark
    Dunleavy, Kieron
    Pittaluga, Stefania
    Kong, Katie
    Shovlin, Margaret
    Jaffe, Elaine S.
    Staudt, Louis M.
    Lai, Catherine
    Chen, Clara C.
    Zheng, Jianbiao
    Willis, Thomas D.
    Faham, Malek
    Wilson, Wyndham H.
    BLOOD, 2014, 124 (21)
  • [3] Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
    Merryman, Reid W.
    Redd, Robert A.
    Taranto, Eleanor
    Ahmed, Gulrayz
    Jeter, Erin
    McHugh, Kristin M.
    Brown, Jennifer R.
    Crombie, Jennifer L.
    Davids, Matthew S.
    Fisher, David C.
    Freedman, Arnold S.
    Jacobsen, Eric
    Jacobson, Caron A.
    Kim, Austin I.
    LaCasce, Ann S.
    Ng, Samuel Y.
    Odejide, Oreofe O.
    Parry, Erin M.
    Jacene, Heather
    Park, Hyesun
    Dahi, Parastoo B.
    Nieto, Yago
    Joyce, Robin M.
    Chen, Yi-Bin
    Shipp, Margaret A.
    Herrera, Alex F.
    Armand, Philippe
    BLOOD ADVANCES, 2023, 7 (17) : 4748 - 4759
  • [4] Emerging drugs for diffuse large B-cell lymphoma
    Mondello, Patrizia
    Younes, Anas
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (04) : 439 - 451
  • [5] Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
    Alcoceba, Miguel
    Stewart, James P.
    Garcia-Alvarez, Maria
    Diaz, Luis G.
    Jimenez, Cristina
    Medina, Alejandro
    Chillon, M. Carmen
    Gazdova, Jana
    Blanco, Oscar
    Diaz, Francisco J.
    Penarrubia, Maria J.
    Fernandez, Silvia
    Montes, Carlos
    Cabero, Almudena
    Caballero, Maria D.
    Garcia-Sanz, Ramon
    Gonzalez, Marcos
    Gonzalez, David
    Tamayo, Pilar
    Gutierrez, Norma C.
    Garcia-Sancho, Alejandro Martin
    Sarasquete, M. Eugenia
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 109 - 121
  • [6] Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma
    Murali Janakiram
    Venu K. Thirukonda
    Matthew Sullivan
    Adam M. Petrich
    Current Treatment Options in Oncology, 2012, 13 : 82 - 101
  • [7] Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma
    Janakiram, Murali
    Thirukonda, Venu K.
    Sullivan, Matthew
    Petrich, Adam M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 82 - 101
  • [8] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [9] Emerging role of histone deacetylase inhibitors in the treatment of diffuse large B-cell lymphoma
    Wang, Mingyang
    Fang, Xiaosheng
    Wang, Xin
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 763 - 775
  • [10] Emerging synthetic drugs for the treatment of diffuse large B-cell lymphoma
    Dong, Ning
    Perez-Lamas, Lucia
    Chavez, Julio C.
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (03) : 181 - 190
12345